Yao Zhu
@yao_zhu_sh
Followers
557
Following
17K
Media
71
Statuses
2K
RT @ChadTangMD: @_ShankarSiva @LancetOncology @MDAndersonNews @myriadgenetics This was a collaboration with @myriadgenetics. WGS of tumor t….
0
1
0
RT @montypal: Terrific talk by @AlbigesL @GustaveRoussy related to #biomarkers in #kidneycancer that spanned #KIM1, #microbiome (MAdCAM-1,….
0
11
0
RT @ChadTangMD: Excited to share our recent @LancetOncology publication on sequential SBRT for oligometastatic clear cell RCC. Our outcomes….
0
67
0
RT @DrChoueiri: New paper from the @AmericanCancer group published @CACancerJournal focused on prostate cancer . @….
0
22
0
RT @Prof_IanD: What a stellar group of people - a privilege to know and work with them.
0
1
0
RT @PBlanchardMD: Another proof that metastasis directed therapy improves outcomes, this time in castration resistant #prostatecancer . Con….
0
85
0
RT @MindyKimGraham: @jclinicalinvest We found that bone marrow myeloid cells were enriched for IFN-γ signaling, priming them for IL-10-medi….
0
1
0
RT @Annals_Oncology: 🆕article in press: Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy….
0
20
0
RT @VanMorrisMD: Addition of PD1 blockade to BRAF+EGFR inhibition with E+C+N offers clear, extended benefit for pts with MSS, BRAF V600E mC….
0
8
0
RT @AndreaNecchi: 📫 Interim results of #Sunrise4 are released @TheLancetOncol .Neoadjuvant #TAR200 + cetrelimab vs cetrelimab monotherapy i….
0
52
0
This case highlights the potential utility of TROP2-Targeted PET/CT for identifying patients likely to benefit from TROP2-directed therapies. Prospective evaluation of sacTMT in metastatic PCa is ongoing.
link.springer.com
European Journal of Nuclear Medicine and Molecular Imaging -
0
2
4
RT @DAVAOnc: Can organoids guide ADC therapy? Dr. Yuan Yuan of @CedarsSinai shares a patient-derived organoid platform preserving tumor & i….
0
1
0
RT @juanosoriomd: CD40 agonist have shown promise but mostly failed due to toxicity and weak activity. We previously showed that 2141-V11,….
0
1
0
RT @ItaiYanai: The difference between doing a project and presenting it. An observation can lead to many avenues of explorations before foc….
0
121
0
RT @montypal: This is huge. Congrats to @tompowles1 @BartsECMC & team who took this from a brilliant paper in @Nature in 2021 to a paradigm….
0
29
0
RT @tompowles1: IMVIGOR011: Atezo vs placebo in ctDNA+ve bladder ca (including -ve becoming +ve) post cystectomy hit OS/PFS. It also tracks….
0
113
0
RT @jclinicalinvest: Metastatic prostate cancer is a leading cause of cancer-related death in men, but little is known about tumor heteroge….
0
8
0
RT @JCO_ASCO: Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: Th….
ascopubs.org
PURPOSEThe high rates of pathologic complete response (pCR) after neoadjuvant immunotherapy have generated interest for a risk adaptive surgical and radiotherapy-free management approach to reduce...
0
7
0
RT @ItaiYanai: A discovery doesn't usually happen as a single moment but in 3 phases:.1. Observing the results from experiments & analyses,….
0
28
0